RGS4 and cancer: Silencing RGS4 controlled the expression of SHANK (SH3 and multiple ankyrin repeat domains) proteins, critical regulators of G-protein signaling that are known to antagonize integrin activation disrupting G-protein interactions along the Rap1-RIAM (Rap1 interacting adaptor molecule)-talin axis in cancer cells and neurons [46].